ea0070aep286 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020
Dischinger Ulrich
, Hasinger Julia
, Königsrainer Malina
, Corteville Carolin
, Otto Cristoph
, Fassnacht Martin
, Hankir Mohamed
, Seyfried Florian
Background: Circulating levels of the appetite-suppressing and glucoregulatory gut hormones glucagon-like peptide 1 (GLP-1) and peptide tyrosine tyrosine 3–36 (PYY3–36) are markedly increased after Roux-en-Y gastric bypass surgery (RYGB), which may contribute to some of its profound metabolic benefits in morbidly obese individuals.Objectives: To directly compare the metabolic effects of chronic systemic administration of the clinic...